Evidence map›Paper›PMID 31197165›Full record

ArticleNature communications2019

Engineering brain activity patterns by neuromodulator polytherapy for treatment of disorders.

Mostafa Ghannad-Rezaie, Peter M Eimon, Yuelong Wu, Mehmet Fatih Yanik

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Fish Capsules: A System for High-Throughput Screening of Combinatorial Drugs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  12. Article
  13. Article
  14. Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  15. Review
  16. Imaging epilepsy in larval zebrafish.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2020
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mostafa Ghannad-RezaieMassachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID http://orcid.org/0000-0003-1928-1909
Peter M EimonMassachusetts Institute of Technology, Cambridge, MA 02139, USA.
Yuelong WuMassachusetts Institute of Technology, Cambridge, MA 02139, USA.
Mehmet Fatih YanikMassachusetts Institute of Technology, Cambridge, MA 02139, USA. yanik@ethz.ch.
Massachusetts Institute of Technology · USSIB Swiss Institute of Bioinformatics · CH

Funding

Generating transplantable neurons by in vivo combinatorial screening of transcripDP1NS082101 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YANIK, MEHMET FATIH · 2012 to 2015
$3.2M
HIGH-THROUGHPUT IN VIVO SUBCELLULAR-RESOLUTION VERTEBRATE SCREENING PLATFORMR01NS073127 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YANIK, MEHMET FATIH · 2010 to 2014
$2.0M
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 818179NINDS NIH HHS DP1 NS082101NINDS NIH HHS R01 NS073127U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) NS073127
6 · The paper itself

Abstract

Conventional drug screens and treatments often ignore the underlying complexity of brain network dysfunctions, resulting in suboptimal outcomes. Here we ask whether we can correct abnormal functional connectivity of the entire brain by identifying and combining multiple neuromodulators that perturb connectivity in complementary ways. Our approach avoids the combinatorial complexity of screening all drug combinations. We develop a high-speed platform capable of imaging more than 15000 neurons in 50ms to map the entire brain functional connectivity in large numbers of vertebrates under many conditions. Screening a panel of drugs in a zebrafish model of human Dravet syndrome, we show that even drugs with related mechanisms of action can modulate functional connectivity in significantly different ways. By clustering connectivity fingerprints, we algorithmically select small subsets of complementary drugs and rapidly identify combinations that are significantly more effective at correcting abnormal networks and reducing spontaneous seizures than monotherapies, while minimizing behavioral side effects. Even at low concentrations, our polytherapy performs superior to individual drugs even at highest tolerated concentrations.

Indexed as

Models, BiologicalAlgorithmsAnimalsAnimals, Genetically ModifiedBehavior, AnimalBrainBrain MappingDisease Models, AnimalDrug Evaluation, PreclinicalDrug SynergismDrug Therapy, CombinationEpilepsies, MyoclonicHigh-Throughput Screening AssaysHumansMicroscopy, ConfocalNerve NetNeurotransmitter Agents

Identifiers

PMID31197165
PMCPMC6565674
OpenAlexW2952326088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.